Royal Bank Of Canada Inmune Bio, Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 20,627 shares of INMB stock, worth $177,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,627

Previous 62,086 66.78%

Holding current value

$177,185

Previous $334,000 71.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.4 - $6.43 $182,419 - $266,581	-41,459 Reduced 66.78%	20,627 $96,000
Q3 2024 Nov 14, 2024	SELL	$4.86 - $9.86 $2,502 - $5,077	-515 Reduced 0.82%	62,086 $334,000
Q2 2024 Aug 14, 2024	SELL	$7.15 - $11.84 $143,965 - $238,398	-20,135 Reduced 24.34%	62,601 $552,000
Q1 2024 Nov 05, 2024	BUY	$10.53 - $14.01 $212,021 - $282,091	20,135 Added 32.16%	82,736 $972,000
Q1 2024 May 15, 2024	BUY	$10.53 - $14.01 $262,670 - $349,479	24,945 Added 43.16%	82,736 $972,000
Q4 2023 Feb 14, 2024	SELL	$6.6 - $11.52 $98,287 - $171,555	-14,892 Reduced 20.49%	57,791 $650,000
Q3 2023 Nov 14, 2023	BUY	$6.61 - $10.9 $15,698 - $25,887	2,375 Added 3.38%	72,683 $492,000
Q2 2023 Aug 14, 2023	BUY	$6.5 - $10.09 $63,498 - $98,569	9,769 Added 16.14%	70,308 $638,000
Q4 2022 Feb 14, 2023	BUY	$6.13 - $7.96 $67 - $87	11 Added 0.02%	60,539 $383,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $10.44 $10,032 - $17,340	1,661 Added 2.82%	60,528 $375,000
Q2 2022 Aug 15, 2022	BUY	$5.48 - $8.97 $39,790 - $65,131	7,261 Added 14.07%	58,867 $520,000
Q1 2022 May 16, 2022	BUY	$6.42 - $11.39 $48,631 - $86,279	7,575 Added 17.2%	51,606 $434,000
Q4 2021 Feb 14, 2022	SELL	$9.97 - $20.38 $821,328 - $1.68 Million	-82,380 Reduced 65.17%	44,031 $449,000
Q3 2021 Nov 15, 2021	BUY	$14.13 - $27.85 $847,135 - $1.67 Million	59,953 Added 90.21%	126,411 $2.46 Million
Q2 2021 Aug 16, 2021	BUY	$9.29 - $19.33 $617,394 - $1.28 Million	66,458 New	66,458 $1.17 Million

Others Institutions Holding INMB

# of Institutions

Shares Held

7.04M

Call Options Held

202K

Put Options Held

42.9K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $154M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Inmune Bio, Inc. Transaction History